Frontiers in Oncology (Nov 2023)

Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC

  • Filippo Tommaso Gallina,
  • Daniele Marinelli,
  • Riccardo Tajè,
  • Daniele Forcella,
  • Gabriele Alessandrini,
  • Fabiana Letizia Cecere,
  • Francesca Fusco,
  • Paolo Visca,
  • Isabella Sperduti,
  • Vincenzo Ambrogi,
  • Federico Cappuzzo,
  • Enrico Melis,
  • Francesco Facciolo

DOI
https://doi.org/10.3389/fonc.2023.1229939
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundDespite notable advances made in preoperative staging, unexpected nodal metastases after surgery are still significantly detected. In this study we aim to analyze the upstaging rate in patients with clinical stage I NSCLC without evidence of nodal disease in the preoperative staging who underwent lobectomy and radical lymphadenectomy.MethodsPatients who underwent lobectomy and systematic lymphadenectomy for clinical stage I NSCLC were evaluated. Exclusion criteria included the neoadjuvant treatment, incomplete resection and no adherence to preoperative guidelines.ResultsA total of 297 patients were included in the study. 159 patients were female, and the median age was 68 (61 - 73). The variables that showed a significant correlation with the upstaging rate at the univariate analysis were the number of resected lymph nodes and micropapillar/solid adenocar-cinoma subtype. This result was confirmed in the multivariate analysis with a OR= 2.545 (95%CI 1.136-5.701; p=0.02) for the number of resected lymph nodes and a OR=2.717 (95%CI 1.256-5.875; p=0.01) for the high-grade pattern of adenocarcinoma.ConclusionOur results showed that in a homogeneous cohort of patients with clinical stage I NSCLC, the number of resected lymph nodes and the histological subtype of adenocarcinoma can significantly be associated with nodal metastasis.

Keywords